|
AU2016266061A1
|
|
Particulate Compositions for Delivery of Poorly Soluble Drugs
|
|
CN108430502A
|
|
Norwalk virus vaccine
|
|
AU2015255693A1
|
|
O-acetylated high molecular weight polygalacturonic acids and their use as Vi polysaccharide vaccine
|
|
CA2945768A1
|
|
Methods of treatment of c. difficile spores with ramoplanin
|
|
WO2015134608A1
|
|
Compositions and methods for oral delivery of encapsulated 3-aminopyridine-2-carboxaldehyde particles
|
|
AU2014277657A1
|
|
Particulate Compositions for Delivery of Poorly Soluble Drugs
|
|
US2013251815A1
|
|
Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
|
|
AU2010206724A1
|
|
Process for preparing particles of opioids and compositions produced thereby
|
|
EP2445877A2
|
|
Bicyclic compounds and methods of making and using same
|
|
AU2009282659A1
|
|
Topical hydrogel composition
|
|
US8026395B1
|
|
Process for the synthesis of anti-neoplasia agent VNP40101M
|
|
WO2009032246A2
|
|
Particulate compositions for delivery of poorly soluble drugs
|
|
WO2007008480A1
|
|
Process for milling and preparing powders and compositions produced thereby
|
|
AU2005286833A1
|
|
Sulfonyl hydrazines as hypoxia-selective antineoplastic agents
|
|
AU2005201757A1
|
|
Methods for coating particles and particles produced thereby
|
|
EP1729829A1
|
|
Compositions for repairing bone and methods for preparing and using such compositions
|
|
US7153272B2
|
|
Methods of collecting and analyzing human breath
|
